Inhibitory effects of dietary soy and whey proteins on muscle atrophy

Inhibitory effects of dietary soy and whey proteins on muscle atrophy - Inhibitory effects of dietary soy and whey proteins on muscle atrophy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028022

Enrollment

Registered

2017-09-01

Start date

2021-01-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

muscle atrophy

Interventions

Whey protein or 8 gram per day, 28 days, with lunch Soy protein + whey protein 8 gram per day, 28 days, with lunch

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients in hospital or Patients with day service Patients with Performance Score 2 or 3

Exclusion criteria

Exclusion criteria: Patients with muscle diseases, chronic kidney diseases, diabetes, steroid treatment, allergy against soy or whey protein Patients getting supplement of soy-derived foods Pregnant women Patients with pace maker Patients with claustrophobia

Design outcomes

Primary

Measure	Time frame
We will give whey protein (8 g/day) or whey + soy proteins (8 g/day) to bed-ridden patients with PS 2 or 3 for 28 days. We will measure the volume and strength of quadriceps muscles.	—

Secondary

Measure	Time frame
We will also measure urinary amounts of 8OHDG and 3-methylhistidine.	—

Countries

Japan

Contacts

Public ContactTakeshi Nikawa

Tokushima University Graduate School Institute of Biomedical Sciences

nikawa@tokushima-u.ac.jp088-633-9248

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026